GO:0030496 midbody: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030496 midbody is a thin cytoplasmic bridge formed between daughter cells at the end of cytokinesis, where the contractile ring constricts.
• The midbody is not merely debris; it acts as a signaling organelle that regulates cell polarity, stemness, and proliferation after mitosis.
• Key protein components include MKLP1, MKLP2, PRC1, ECT2, RhoA, and centralspindlin, which orchestrate midbody assembly and abscission.
• Midbody remnants can regulate primary cilia formation and influence tumor growth, linking them to cancer biology.
• Midbody proteins display distinct dynamics during cytokinesis, with some acting as back-up sources of microtubules.
• CRISPR-based models (knockout, knock-in, overexpression) are essential to dissect midbody gene function and its role in disease.
Description
The midbody (GO:0030496) is a specialized cellular structure that forms at the end of cytokinesis, serving as a thin cytoplasmic bridge between daughter cells before abscission. It is defined as a thin cytoplasmic bridge formed between daughter cells at the end of cytokinesis, forming where the contractile ring constricts and may persist before finally breaking to complete cytokinesis. This structure is critical for proper cell division and has emerged as a signaling hub that regulates cell polarity, stemness, and proliferation after mitosis. Researchers study the midbody to understand fundamental mechanisms of cytokinesis and its implications in cancer, developmental biology, and regenerative medicine. The midbody is composed of a complex network of proteins, including centralspindlin, MKLP1, MKLP2, PRC1, and ECT2, which coordinate microtubule bundling and membrane abscission. Recent studies have highlighted that the midbody and its remnant are not passive debris but active signaling organelles with diagnostic and therapeutic potential. Understanding the midbody's molecular composition and regulation is essential for uncovering new targets in diseases characterized by aberrant cell division, such as cancer.
midbody At A Glance
| GO ID | GO:0030496 |
|---|---|
| GO term | midbody |
| Ontology | cellular_component |
| Synonym | none |
| Major function | Thin cytoplasmic bridge formed between daughter cells at the end of cytokinesis; regulates polarity, stemness, and proliferation |
| Definition | A thin cytoplasmic bridge formed between daughter cells at the end of cytokinesis. The midbody forms where the contractile ring constricts, and may persist for some time before finally breaking to complete cytokinesis. |
| Related structures | Midbody remnant, primary cilia, contractile ring |
| Key proteins | MKLP1, MKLP2, PRC1, ECT2, RhoA, centralspindlin |
What Is GO:0030496?
The midbody is a thin cytoplasmic bridge that forms between daughter cells at the end of cytokinesis. It arises where the contractile ring constricts and may persist for some time before finally breaking to complete cytokinesis. This structure is essential for the final separation of daughter cells and serves as a platform for signaling events that influence cell fate and polarity.
Why Is midbody Important in Cell Biology?
The midbody is important because it is not only a structural element required for the completion of cytokinesis but also a signaling organelle that regulates cell polarity, stemness, and proliferation after mitosis. Dysregulation of midbody components has been linked to tumor growth and cancer progression, making it a potential diagnostic and therapeutic target. Understanding the midbody's role in asymmetric cell division and cell polarization provides insights into developmental processes and tissue homeostasis.
• Essential for completing cytokinesis and preventing binucleation or aneuploidy.
• Acts as a signaling platform that influences cell polarity and asymmetric cell division.
• Regulates stemness and proliferation in postmitotic cells.
• Midbody remnants can regulate primary cilia formation, impacting tumor growth.
• Dysregulation of midbody proteins is associated with cancer and developmental defects.
• Provides a target for therapeutic intervention in diseases of aberrant cell division.
• Midbody proteins display distinct dynamics, offering insights into temporal regulation of cytokinesis.
• Back-up sources of microtubules for the midbody ensure robust abscission.
• Translational regulation at the midbody controls cytokinesis fidelity.
• Midbody remnants serve as diagnostic markers in cancer and other diseases.
Core Biology of the midbody (GO:0030496)
What Happens During midbody?
In simple terms: The midbody forms when a cell divides and the bridge between the two new cells tightens, creating a thin connection that eventually breaks.
During cytokinesis, the contractile ring constricts to form a thin cytoplasmic bridge between daughter cells, known as the midbody. This structure persists until abscission, the final separation step. The midbody serves as a scaffold for proteins that regulate abscission and also acts as a signaling hub that can influence cell fate after division. Midbody remnants can be inherited by one daughter cell and regulate processes such as primary cilia formation and tumor growth.
Structure and Composition of midbody
In simple terms: The midbody is made of a bundle of microtubules and many proteins that hold it together and help it signal.
The midbody is composed of a dense bundle of antiparallel microtubules and a complex of proteins including centralspindlin (MKLP1 and CYK-4), MKLP2, PRC1, ECT2, and RhoA. These proteins coordinate microtubule bundling, membrane trafficking, and abscission. The midbody also contains components of the ESCRT machinery, which mediates the final membrane scission. Recent studies have shown that midbody proteins display distinct dynamics during cytokinesis, with some acting as back-up sources of microtubules.
Molecular Mechanism of midbody
In simple terms: Proteins in the midbody work together to pinch the cell membrane and cut the bridge, while also sending signals.
The molecular mechanism of midbody function involves the recruitment of centralspindlin and other proteins to the midzone, where they bundle microtubules and recruit ESCRT-III components to mediate abscission. RhoA activation at the midbody regulates actin dynamics and contractility. Additionally, the midbody can serve as a platform for translational regulation, as shown by the translation of specific mRNAs at the midbody during cytokinesis. The midbody remnant can then be inherited and influence cell polarity and asymmetric cell division.
Regulation of midbody assembly and disassembly
In simple terms: The formation and breakdown of the midbody are controlled by a series of molecular switches.
Midbody assembly is regulated by the centralspindlin complex and Aurora B kinase, which phosphorylates components to ensure proper localization. Abscission is triggered by ESCRT-III recruitment and membrane remodeling, and is tightly coupled to cell cycle progression. The midbody remnant can persist for hours and is eventually cleared or inherited, with its fate influenced by cell type and context. Dysregulation of these processes can lead to cytokinesis failure and genomic instability.
Key Genes Involved in GO:0030496 midbody
The following genes and proteins are key components of the midbody and play critical roles in its assembly, function, and regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MKLP1 (KIF23) | Centralspindlin component; microtubule bundling | Essential for midbody formation; knockout causes cytokinesis failure |
| MKLP2 (KIF20A) | Aurora B recruitment; midbody maturation | Regulates abscission timing; implicated in cancer |
| PRC1 | Microtubule crosslinking; midzone organization | Required for midbody integrity; knockout leads to binucleation |
| ECT2 | RhoA activator; contractile ring formation | Regulates midbody assembly; overexpression in tumors |
| RhoA | GTPase; actin dynamics | Controls contractility; mutations affect cytokinesis |
| CYK-4 (MGCRACGAP) | Centralspindlin component; RhoA regulation | Essential for central spindle and midbody |
| Aurora B (AURKB) | Kinase; chromosome segregation and abscission | Regulates midbody protein phosphorylation |
| ESCRT-III (CHMP4B) | Membrane scission | Mediates abscission; mutations cause cytokinesis defects |
| CEP55 | Midbody recruitment; abscission | Marker of midbody; involved in cancer |
| Anillin (ANLN) | Actin binding; contractile ring | Required for midbody stability |
| KIF14 | Microtubule motor; midbody localization | Implicated in cytokinesis and cancer |
| Citron kinase (CIT) | RhoA effector; contractile ring | Regulates midbody formation |
| PLK1 | Kinase; mitotic progression | Phosphorylates midbody components |
| Survivin (BIRC5) | Chromosomal passenger complex | Regulates midbody assembly |
| INCENP | Chromosomal passenger complex | Required for Aurora B activation at midbody |
| Borealin (CDCA8) | Chromosomal passenger complex | Regulates midbody protein dynamics |
| RACGAP1 | Centralspindlin component | Essential for midbody formation |
| KIF4A | Chromosome condensation; midbody | Regulates midbody microtubule dynamics |
How Is midbody Regulated?
The midbody is regulated by multiple signaling pathways, including the RhoA-ROCK pathway, which controls actomyosin contractility, and the Aurora B kinase pathway, which ensures proper chromosome segregation and abscission. Translational regulation at the midbody also plays a role, with specific mRNAs being translated locally to control cytokinesis. Additionally, the fate of the midbody remnant is influenced by cell polarity cues and can affect asymmetric cell division.
midbody and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MKLP2 (KIF20A) | Cancer progression | Knockout in cancer cell lines; xenograft models |
| ECT2 | Tumor growth | Overexpression in cancer cells; CRISPR knock-in |
| PRC1 | Developmental defects | Knockout mouse models; point mutations |
| CEP55 | Cancer and cytokinesis defects | Knockout and tagged knock-in in cell lines |
| Aurora B (AURKB) | Cancer and chromosomal instability | Point mutation knock-in; inhibitor studies |
Midbody in Cancer
Dysregulation of midbody components is frequently observed in cancer. For example, overexpression of MKLP2 and ECT2 is associated with tumor progression and poor prognosis. Midbody remnants can regulate primary cilia formation, which in turn affects tumor growth and signaling. Targeting midbody proteins may offer therapeutic opportunities in cancers characterized by aberrant cytokinesis.
Midbody in Developmental Disorders
Mutations in genes encoding midbody proteins, such as MKLP1 and PRC1, can lead to cytokinesis failure and developmental defects. These defects often result in binucleation, aneuploidy, and impaired tissue development. Understanding the midbody's role in asymmetric cell division is crucial for developmental biology.
Midbody in Neurodegeneration
Emerging evidence suggests that midbody remnants may influence neuronal polarity and survival, although the link to neurodegeneration requires further investigation. Dysregulation of cytokinesis in neurons can lead to cell death, but direct evidence for midbody involvement in neurodegenerative diseases is limited.
From midbody-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate midbody assembly? | CRISPR knockout in HeLa or HEK293 cells |
| What is the role of a specific phosphorylation site in midbody protein? | Point mutation knock-in (e.g., phospho-deficient) |
| How does a disease-associated mutation affect midbody function? | Knock-in of patient mutation in cell lines |
| Where does a protein localize during cytokinesis? | Tagged knock-in (e.g., GFP) for live imaging |
| Does overexpression of gene X drive tumor growth? | Overexpression in cancer cell lines and xenografts |
| What is the interactome of midbody proteins? | Affinity purification mass spectrometry with tagged knock-in |
How to Study the midbody Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Midbody dynamics and abscission timing | Tracking GFP-tagged proteins |
| Immunofluorescence | Localization of midbody proteins | Fixed cell analysis |
| Mass spectrometry | Protein composition and interactions | Midbody proteome |
| CRISPR knockout screens | Gene essentiality for cytokinesis | Identifying novel midbody regulators |
| Ribo-seq | Local translation at midbody | Translational regulation |
| Proximity ligation assay | Protein-protein interactions in situ | Midbody complex assembly |
| Electron microscopy | Ultrastructure of midbody | Detailed morphology |
| Flow cytometry | Cell cycle and ploidy | Detecting cytokinesis failure |
Imaging of the Midbody
Fluorescence microscopy, including live-cell imaging, is essential to visualize midbody formation and dynamics. Tagged knock-in of midbody proteins (e.g., GFP-MKLP1) allows real-time tracking of assembly and abscission.
Proteomic Analysis
Mass spectrometry-based proteomics can identify midbody components and their post-translational modifications. Affinity purification of midbody fractions followed by LC-MS/MS reveals interaction networks.
Functional Genomics
CRISPR knockout screens and RNAi can systematically test the role of genes in cytokinesis. High-content imaging of binucleation or midbody markers identifies essential regulators.
Translational Profiling
Ribo-seq and polysome profiling can detect local translation at the midbody, revealing how specific mRNAs are translated during cytokinesis.
How CRISPR Can Be Used to Study GO:0030496 midbody
Knockout
CRISPR knockout of midbody genes (e.g., MKLP1, PRC1) in cell lines leads to cytokinesis failure, binucleation, and cell death, providing direct evidence for their essential roles.
Point Mutation
Point mutation knock-in can dissect the function of specific residues, such as phosphorylation sites in Aurora B substrates, to understand midbody regulation.
Knock-in
Knock-in of tagged versions (e.g., GFP, HaloTag) of midbody proteins enables live imaging and proteomic analysis without altering endogenous expression levels.
Overexpression
Overexpression of midbody genes such as ECT2 or MKLP2 can drive tumorigenesis and is used to model cancer progression and identify therapeutic targets.
How EDITGENE Supports midbody Research
Researchers studying midbody-related genes often need to determine whether a candidate gene is causally involved in cytokinesis, cell polarity, or disease progression. EDITGENE provides comprehensive CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for midbody research.
Frequently Asked Questions About midbody
What is the midbody (GO:0030496)?
The midbody is a thin cytoplasmic bridge formed between daughter cells at the end of cytokinesis, where the contractile ring constricts, and it may persist before breaking to complete cytokinesis.
What genes are involved in the midbody?
Key genes include MKLP1 (KIF23), MKLP2 (KIF20A), PRC1, ECT2, RhoA, CEP55, and Aurora B (AURKB).
What is the function of the midbody?
The midbody is essential for completing cytokinesis and also acts as a signaling organelle regulating cell polarity, stemness, and proliferation.
How is the midbody regulated?
It is regulated by RhoA-ROCK signaling, Aurora B kinase, and local translation of specific mRNAs.
What diseases are associated with midbody dysfunction?
Midbody dysfunction is linked to cancer, developmental defects, and potentially neurodegeneration.
What is the midbody remnant?
The midbody remnant is the post-abscission structure that can be inherited by one daughter cell and regulate primary cilia formation and tumor growth.
How can I study the midbody using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of midbody genes.
What methods are used to study the midbody?
Live-cell imaging, immunofluorescence, mass spectrometry, and CRISPR screens are common methods.
Is the midbody a therapeutic target?
Yes, midbody proteins are potential targets for cancer therapy due to their role in tumor growth and cytokinesis.
What is the difference between midbody and midbody remnant?
The midbody is the bridge during cytokinesis; the remnant is what remains after abscission and can persist as a signaling organelle.
Conclusion
The midbody (GO:0030496) is a dynamic cellular structure essential for cytokinesis and postmitotic signaling. Its complex protein composition and regulation make it a key area of research in cell division, cancer, and developmental biology. Understanding the midbody's molecular mechanisms offers opportunities for therapeutic intervention in diseases characterized by aberrant cytokinesis.
References
- 1. Peterman E et al.. 2019. The postmitotic midbody: Regulating polarity, stemness, and proliferation.. J Cell Biol 218(12):3903-3911 PMID: 31690620
- 2. Li Z et al.. 2024. Midbody remnant regulates the formation of primary cilia and their roles in tumor growth.. Zhejiang Da Xue Xue Bao Yi Xue Ban 53(2):261-268 PMID: 38413234
- 3. Kuriyama R et al.. 2025. The midbody and midbody remnant: from cellular debris to signaling organelle with diagnostic and therapeutic potential.. Mol Biol Cell 36(7):re4 PMID: 40434898
- 4. Antanavičiūtė I et al.. 2018. Midbody: From the Regulator of Cytokinesis to Postmitotic Signaling Organelle.. Medicina (Kaunas) 54(4) PMID: 30344284
- 5. Halcrow EFJ et al.. 2022. Midbody Proteins Display Distinct Dynamics during Cytokinesis.. Cells 11(21) PMID: 36359734
- 6. Hickson GRX. 2022. A back-up source of microtubules for the midbody during cytokinesis.. J Cell Biol 221(3) PMID: 35191950
- 7. Heinke L. 2024. Translating the midbody for cytokinesis.. Nat Rev Mol Cell Biol 25(2):85 PMID: 38195736
- 8. Pohl C. 2017. The Midbody and its Remnant in Cell Polarization and Asymmetric Cell Division.. Results Probl Cell Differ 61:165-182 PMID: 28409304
